Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · April 15, 2022

Tumor Budding as an Independent Prognostic Factor for Stage III Colon Cancer

Annals of Oncology

 

Additional Info

Annals of Oncology
Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
Ann. Oncol 2022 Mar 16;[EPub Ahead of Print], D Basile, C Broudin, JF Emile, A Falcoz, F Pagès, L Mineur, J Bennouna, C Louvet, P Artru, S Fratte, F Ghiringhelli, T André, V Derangère, D Vernerey, J Taieb, M Svrcek

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading